71461-30-8Relevant articles and documents
A novel method to produce synthetic murine CXCL10 for efficient screening of functional variants
Decalf, Jérémie,Tom, Jeffrey,Mai, Elaine,Hernandez-Barry, Hilda,Noland, Cameron L.,Vollmar, Breanna S.,Li, Alice,Li, Hong,Xie, Daniel,Zhu, Lunchao,Payandeh, Jian,Wu, Cong,Comps-Agrar, Laetitia,Moussion, Christine,Albert, Matthew L.,Song, Aimin
, (2021/09/28)
Antitumor immune responses depend on the infiltration of solid tumors by effector T cells, a process guided by chemokines. In particular, the chemokine CXCL10 has been shown to play a critical role in mediating recruitment of CXCR3 + cytolytic T and NK ce
Efficient synthesis of methyl (S)-4-(1-methylpyrrolidin-2-YL)-3-oxobutanoate as the key intermediate for tropane alkaloid biosynthesis with optically acitve form
Katakam, Nanda Kumar,Seifert, Cole W.,D'Auria, John,Li, Guigen
, p. 604 - 613 (2019/08/01)
Methyl (S)-4-(1-methylpyrrolidin-2-yl)-3-oxobutanoate has been synthesized for enzymatic studies on cyclization enzymes during cocaine biosynthesis in Erythroxylum coca plants. During the present new synthesis, L-proline was first protected with Cbz group and reduced to chiral amino alcohol, which were then followed by Swern oxidation, Wittig reaction and decarboxylative condensation. At the last step, N-methylamino acid precursor was treated with 1,1'-carbonyldiimidazole followed by reacting with methyl potassium malonate to give the 3-oxobutanoate in 54% overall yield. This new strategy has proven to avoid obvious racemization of the L-proline chiral center during the synthesis. In addition, six of the eight synthesis steps were performed via GAP chemistry/technology without the use of column chromatography for purification.
FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
-
Paragraph 00185, (2017/03/08)
Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.